Rs 14.60 crore SME IPO, launched on Tuesday, February 4, is priced between Rs 47-50 per share, with a minimum lot size of ...
Singapore-based Uni-Fuels Holdings has raised an additional $1.26m through selling another tranche of 315,000 Class A shares, ...
RADNOR, PA / ACCESS Newswire / February 13, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a ...
centers on the company’s STRIDES Phase 2 clinical trial for azelaprag, an investigational drug. The suit claims that offering documents for BioAge’s IPO, which raised $227.7 million by selling ...
Chamunda Electricals unlisted shares were trading at around Rs 61 apiece, indicating a grey market premium (GMP) of Rs 11 or ...
The IPO of Chamunda Electricals was open for bidding between February 4 and February 6, selling its shares in the price band ...
Chamunda Electricals is looking to raise a total of Rs 14.60 crore via IPO, which is entirely a fresh share sale of 29,19,000 ...
The law firm of Kirby McInerney LLP reminds investors of the March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired ...
BioAge Labs, Inc., filed in the U.S. District Court for the Northern District of California, centers on the company's STRIDES Phase 2 clinical trial for azelaprag, an investigational drug. The suit ...
Bill Zarkalis, Titan America CEO, joins 'The Exchange' to discuss the company's debut on the New York Stock Exchange.
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results